Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.420
-0.005 (-1.20%)
At close: Feb 21, 2025, 4:00 PM
0.402
-0.018 (-4.36%)
After-hours: Feb 21, 2025, 4:56 PM EST
Spruce Biosciences Revenue
Spruce Biosciences had revenue of $602.00K in the quarter ending September 30, 2024, a decrease of -80.41%. This brings the company's revenue in the last twelve months to $7.10M, down -1.40% year-over-year. In the year 2023, Spruce Biosciences had annual revenue of $10.09M.
Revenue (ttm)
$7.10M
Revenue Growth
-1.40%
P/S Ratio
2.43
Revenue / Employee
$244,862
Employees
29
Market Cap
17.35M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
SPRB News
- 2 months ago - Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder - Benzinga
- 2 months ago - Spruce Biosciences to wind down investment for genetic disorder drug - Reuters
- 2 months ago - Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH - Business Wire
- 3 months ago - Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Business Wire
- 3 months ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out - Accesswire
- 4 months ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Take Part - Accesswire
- 4 months ago - Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference - Business Wire
- 4 months ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholder Participation - Accesswire